(Q42858044)

8 November 2017

Quantitative chemical proteomics reveals a Plk1 inhibitor-compromised cell death pathway in human cells (English)

1 reference

8 November 2017

8

1 reference

8 November 2017

Monika Raab

1

1 reference

8 November 2017

Fiona Pachl

2

1 reference

8 November 2017

Andrea Krämer

3

1 reference

8 November 2017

Elisabeth Kurunci-Csacsko

4

1 reference

8 November 2017

Christina Dötsch

5

1 reference

8 November 2017

Rainald Knecht

6

1 reference

8 November 2017

Sven Becker

7

1 reference

8 November 2017

Klaus Strebhardt

9

1 reference

8 November 2017

1 July 2014

1 reference

8 November 2017

1 reference

8 November 2017

24

1 reference

8 November 2017

9

1 reference

8 November 2017

1141-1145

1 reference

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

8 November 2017

start time

1 July 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/cr.2014.86

0 references

cites work

A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4152744

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4152744

Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4152744

Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4152744

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4152744

The death-associated protein kinases: structure, function, and beyond

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4152744

Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4152744

The pro-apoptotic function of death-associated protein kinase is controlled by a unique inhibitory autophosphorylation-based mechanism

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4152744

Nucleotide binding by the histidine kinase CheA

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4152744

DAP-kinase is a Ca2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4152744

Antagonistic binding of substrates to 3-phosphoglycerate kinase monitored by the fluorescent analogue 2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4152744

A comparison of labeling and label-free mass spectrometry-based proteomics approaches.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4152744

Targeting polo-like kinase 1 for cancer therapy.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4152744

Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24980956

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/CR.2014.86

1 reference

Dimensions Publication ID

8 November 2017

0 references

1 reference

8 November 2017

1 reference